About CVPath

BOARD OF DIRECTORS

arrowAzin Parhizgar, PhD

Dr. Parhizgar is the Chair of the CVPath Board of Directors and has been a member of the Board since 2008.

She is an experienced and successful medical device industry executive and entrepeneur. Most recently she served as the Chief Operating Officer of Conor Medsystems which led to the acquisition of the company by Johnson & Johnson, Inc. in 2007. Between 1996-2000 she was the Executive VP of Arterial Vascular Engineering which was acquired by Medtronic,Inc. She spent 2 years at Medtronic Inc post merger in increasing roles of responsibility leading to her role as Executive Vice President of Emerging Ventures and New Technologies. Dr. Parhizgar currently serves as an advisor to emerging medical device technology companies including several Board of Director and Scientific Advisory Board positions.

Dr. Parhizgar received both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University, Providence, RI.

arrowRenu Virmani, MD

Dr. Virmani is the Founder, President, and Medical Director of CVPath Institute. She has been a member of the Board since 2006.

For more about Dr. Virmani, please click here.

arrowMoshe Flugelman, MD

Dr. Flugelman has been a member of the Board since 2009.

Dr. Flugelman specializes in interventional cardiology and vascular biology. He is the Director of the In-Patient Cardiology Service and Associate Director of the Department of Cardiovascular Medicine at the Lady David Carmel Medical Center. He was a visiting scientist at the National Heart, Lung & Blood Institute of the National Institutes of Health (NIH) in Bethesda, Maryland, and fellow in experimental angioplasty at Washington Hospital Center, Washington, DC. While at the NIH, Dr. Flugelman worked with leading experts in vascular gene therapy. Dr. Flugelman has broad experience in the fields of experimental cardiology and vascular biology. Dr. Flugelman earned his medical degree at the Technion, Israel Institute of Technology (Haifa, Israel) and completed his cardiology training at the Hadassah Hebrew University Medical Center in Jerusalem.

Dr. Moshe Flugelman is also the co-founder of MultiGene Vascular Systems, a biotechnology company focusing on the treatment of peripheral and coronary artery disease.

arrowChester E Finn, Jr., Phd

Dr. Finn has been a member of the Board since 2006.

Chester E. Finn, Jr., has devoted his career to improving education in the United States. He is a Senior Fellow at Stanford’s Hoover Institution and Chairman of Hoover’s Koret Task Force on K-12 Education, President of the Thomas B. Fordham Institute, and Senior Editor of Education Next.

Dr. Finn is also an Adjunct Fellow at the Hudson Institute, where he worked from 1995 through 1998. From 1999 until 2002, he was John M. Olin Fellow at the Manhattan Institute. In 1992-1994, he served as founding partner and senior scholar with the Edison Project. He was Professor of Education and Public Policy at Vanderbilt University from 1981 until 2002. From 1985 to 1988, he served as Assistant Secretary for Research and Improvement & Counselor to the Secretary at the U.S. Department of Education. Earlier positions include Staff Assistant to the President of the United States; Special Assistant to the Governor of Massachusetts; Counsel to the U.S. Ambassador to India; Research Associate at the Brookings Institution; and Legislative Director for Senator Daniel Patrick Moynihan.

A native of Ohio, he holds an undergraduate degree in U.S. history, a master’s degree in social studies teaching, and a doctorate in education policy, all from Harvard University. He also holds an honorary Doctor of Laws degree from Colgate University.

Dr. Finn has served on numerous boards of directors, including most recently, the National Council on Teacher Quality and the Philanthropy Roundtable. From 1988-96, he served on the National Assessment Governing Board, including two years as its chair. In 2004-5, he served on the Governor’s Commission on Quality Education in Maryland.

Dr. Finn is also the author of 19 books and more than 400 articles in such publications as the Wall Street Journal, Washington Post, New York Times, Harvard Business Review, and Boston Globe.

arrowWoody Peterson, J.D.

Mr. Peterson has been a member of the Board since 2006.

Woody Peterson is a partner at Dickstein Shapiro. He joined the firm in 1980 and is a partner in the firm’s Business Litigation Practice. His practice focuses on appellate litigation. Mr. Peterson has authored or co-authored numerous briefs in the federal courts of appeals and state appellate courts, as well as petitions for certiorari, briefs in opposition, and amicus briefs in the Supreme Court of the United States. The briefs have spanned subject areas as diverse as energy, antitrust, ERISA, securities, defamation, employment, insurance coverage, and intellectual property. Mr. Peterson earned his bachelor’s degree, graduating magna cum laude, from Harvard University in 1970. He graduated cum laude with his J.D. in 1976, also from Harvard University.

arrowAndrew Braumann

Mr. Braumann has been a member of the Board since 2006.

Andrew M. Braumann, is a Vice President, with BB&T Bank. He has over 25 years of banking experience serving in various positions in the banking and financial services industries. He is an advisor who provides comprehensive advice and customized financial solutions.

Andrew earned a BBA in Marketing and his MBA in Finance and Investments from The George Washington University, in Washington, DC. He holds the NASD series 7, 63, and 65 licenses, and the Virginia Life Annuities & Health Insurance license.

arrowAloke Finn, MD

For more about Dr. Finn, please click here.

NEWS & EVENTS